Inducible activation of CEBPB, a gene negatively regulated by BCR/ABL, inhibits proliferation and promotes differentiation of BCR/ABL-expressing cells.
about
Src homology 2 domain-containing inositol-5-phosphatase and CCAAT enhancer-binding protein beta are targeted by miR-155 in B cells of Emicro-MiR-155 transgenic miceThe Philadelphia chromosome in leukemogenesismiR-155: A Novel Target in Allergic AsthmaC/EBP-beta regulates endoplasmic reticulum stress-triggered cell death in mouse and human modelsA gene expression signature of CD34+ cells to predict major cytogenetic response in chronic-phase chronic myeloid leukemia patients treated with imatinib.Chronic myeloid leukemia: mechanisms of blastic transformationThe biological effects of C/EBPalpha in K562 cells depend on the potency of the N-terminal regulatory region, not on specificity of the DNA binding domain.MYC-regulated genes involved in liver cell dysplasia identified in a transgenic model of liver cancer.Cyclic AMP responsive element binding proteins are involved in 'emergency' granulopoiesis through the upregulation of CCAAT/enhancer binding protein βUpregulated microRNA-92b regulates the differentiation and proliferation of EpCAM-positive fetal liver cells by targeting C/EBPß.MUC1-C oncoprotein suppresses reactive oxygen species-induced terminal differentiation of acute myelogenous leukemia cellsC/EBPβ promotes BCR-ABL-mediated myeloid expansion and leukemic stem cell exhaustion.High levels of the BCR/ABL oncoprotein are required for the MAPK-hnRNP-E2 dependent suppression of C/EBPalpha-driven myeloid differentiationNon-steady-state hematopoiesis regulated by the C/EBPβ transcription factor.Altered CELF1 binding to target transcripts in malignant T cells.Long noncoding RNA TUG1 is downregulated in non-small cell lung cancer and can regulate CELF1 on binding to PRC2.CELF1 is Up-Regulated in Glioma and Promotes Glioma Cell Proliferation by Suppression of CDKN1BMiR-362-5p promotes the malignancy of chronic myelocytic leukaemia via down-regulation of GADD45α.Identification of novel posttranscriptional targets of the BCR/ABL oncoprotein by ribonomics: requirement of E2F3 for BCR/ABL leukemogenesis.ReSETting PP2A tumour suppressor activity in blast crisis and imatinib-resistant chronic myelogenous leukaemia.CELFish ways to modulate mRNA decay.High Expression of CPT1A Predicts Adverse Outcomes: A Potential Therapeutic Target for Acute Myeloid Leukemia.BCR-ABL1 kinase-dependent alteration of mRNA metabolism: potential alternatives for therapeutic intervention.Expression of CCL9/MIP-1gamma is repressed by BCR/ABL and its restoration suppresses in vivo leukemogenesis of 32D-BCR/ABL cells.Natural course and biology of CML.CUGBP1 promotes cell proliferation and suppresses apoptosis via down-regulating C/EBPα in human non-small cell lung cancers.Downregulation of BRCA1 protein in BCR-ABL1 leukemia cells depends on stress-triggered TIAR-mediated suppression of translation.Lentivirus-mediated knockdown of CUGBP1 suppresses gastric cancer cell proliferation in vitro.Post-transcriptional regulation of cytokine and growth factor signaling in cancer.Identification of key genes induced by platelet-rich plasma in human dermal papilla cells using bioinformatics methods.Repression of STAT3, STAT5A, and STAT5B expressions in chronic myelogenous leukemia cell line K-562 with unmodified or chemically modified siRNAs and induction of apoptosis.Ectopic expression of cyclin D3 corrects differentiation of DM1 myoblasts through activation of RNA CUG-binding protein, CUGBP1.Leukemogenesis induced by wild-type and STI571-resistant BCR/ABL is potently suppressed by C/EBPalpha.Oxidative stress promotes transcriptional up-regulation of Fyn in BCR-ABL1-expressing cells.Airway epithelial cell differentiation during lung organogenesis requires C/EBPα and C/EBPβ.Liver-enriched activator protein 1 as an isoform of CCAAT/enhancer-binding protein beta suppresses stem cell features of hepatocellular carcinoma.A112, a tamibarotene dimethylaminoethyl ester, may inhibit human leukemia cell growth more potently than tamibarotene.Transcriptional Regulation of Emergency Granulopoiesis in Leukemia.JMJD3 facilitates C/EBPβ-centered transcriptional program to exert oncorepressor activity in AML
P2860
Q24651080-4B45DD35-5B57-4559-9CFD-FEE00A8B9F3CQ26745531-CB14404A-0ADC-4052-B0AB-F7B49CA08121Q28077478-BE894B26-345E-47A3-9469-98D93294A674Q28748676-168FFE6C-E938-469C-B0F1-D74CA0B2EF55Q33597519-DDB76D2A-CC85-4013-80A1-1BCD87BA549DQ33968037-7BD5D991-1E50-4870-9F7C-25B7FA594075Q34155377-93D846B7-A447-4755-A4FE-9208018E72C6Q34288613-C1ED5A8A-0856-48B8-8A9C-FAE093A23C10Q34575761-281A426C-EE8C-460B-9D31-9F3F6049C019Q34924005-BC29DD7F-5D2B-47B3-B9E9-A733C947B7C9Q35001632-4D41B089-31BE-461C-8A54-80D53050426CQ35864103-CE7A945A-92EB-4687-934E-D131B5AB7444Q35901685-5CEB900F-B9E3-4D65-B8FF-A4C03A4C11A1Q35904180-AFF663CC-0844-42F8-B81A-06250CC3422BQ36072305-3CC41807-529D-4DE7-BAD5-B08949CA9D53Q36093282-1880B049-8EA2-47BE-8AFF-39F71221FCD2Q36222881-284276C9-58FD-4914-997A-50DDF225B940Q36259116-8369AB1A-E5AC-4B65-9999-3B34BBD38451Q36384790-15E1CB2C-4EFE-4BA3-93AF-130C53BC0227Q36585748-C8755868-33BC-48B1-BD9E-24B1E2F9FC08Q36807677-600ABBE5-9D19-45B1-800B-225D74D14130Q37510247-9840CC4C-A708-4F20-AB4D-4C210E3016D9Q37836928-E962CCCE-E819-4F8C-9C76-D26B110D233DQ38306649-63EF5FEC-09BF-4751-BF40-4C041A8A3886Q38392667-3F9FA3B0-58A6-4475-BA8F-33C9DD8F42DDQ38907606-B9085A2E-224E-4B00-A7B4-752502E37EF2Q38931383-0F030CE3-C4F7-494B-94B2-7DF27F655647Q38995962-A21D5E99-78A3-41F4-B248-340ECC3EA437Q39036700-38C60BEE-747F-4B2D-85E4-48B159351E0AQ39127021-8808B717-F41B-4493-986B-24A45A0419C4Q39262510-29885D94-5757-45DE-8715-0E7F9ADEC9E8Q39969644-83FB34CC-C5FB-4184-9B8D-75DF90BCD5DFQ42119907-B8E2A5B9-2657-445F-8983-E6E41BBEA76DQ42186300-29CF0532-3480-427E-827F-37C3D831505DQ51804603-0AA7D66E-B011-4D7F-8A03-6A17C57A41C8Q53946052-07ED9793-A53E-405C-A933-3DFA2907C9AEQ54567573-8678FCA6-8D27-472B-8D6D-95F949EC4955Q55091743-BED1F76C-C622-4B1A-A71B-1663CACE55E7Q58721755-AD51D4E9-ACAA-43D5-8832-0027F905930C
P2860
Inducible activation of CEBPB, a gene negatively regulated by BCR/ABL, inhibits proliferation and promotes differentiation of BCR/ABL-expressing cells.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Inducible activation of CEBPB, ...... n of BCR/ABL-expressing cells.
@en
Inducible activation of CEBPB, ...... n of BCR/ABL-expressing cells.
@nl
type
label
Inducible activation of CEBPB, ...... n of BCR/ABL-expressing cells.
@en
Inducible activation of CEBPB, ...... n of BCR/ABL-expressing cells.
@nl
prefLabel
Inducible activation of CEBPB, ...... n of BCR/ABL-expressing cells.
@en
Inducible activation of CEBPB, ...... n of BCR/ABL-expressing cells.
@nl
P2093
P2860
P1433
P1476
Inducible activation of CEBPB, ...... n of BCR/ABL-expressing cells.
@en
P2093
Bruno Calabretta
Clara Guerzoni
Danilo Perrotti
Giovanna Ferrari-Amorotti
Maria Luisa Panno
Michela Bardini
Paolo Neviani
Robert Martinez
Samanta A Mariani
Ying Zhang
P2860
P304
P356
10.1182/BLOOD-2005-08-3181
P407
P577
2006-01-17T00:00:00Z